BioPharma Dive - Latest News

Leqembi’s EU review drags on; Sanofi gets a new development head

The European Commission has referred Eisai and Biogen’s application to an appeals committee. Elsewhere, Opthea warned of insolvency and Novartis hired a new top lawyer.

Apr 2, 2025 - 17:29
 0
Leqembi’s EU review drags on; Sanofi gets a new development head

The European Commission has referred Eisai and Biogen’s application to an appeals committee. Elsewhere, Opthea warned of insolvency and Novartis hired a new top lawyer.

Read More

Tags:

Previous Article

Converting A Honda Prelude To Four-Wheel Drive Is Easy: Just Add Another Engine

Next Article

Supreme Court sides with the FDA in its dispute over sweet-flavored vaping products

Related Posts

Cargo shelves cell therapy research and lays off almost all staff

Cargo shelves cell therapy research and lays off almost...

Mar 19, 2025  0

Novo outlines new late-stage study of obesity drug CagriSema

Novo outlines new late-stage study of obesity drug Cagr...

Feb 9, 2025  0

Bayer braces for ‘difficult’ year before turnaround pays dividends

Bayer braces for ‘difficult’ year before turnaround pay...

Mar 5, 2025  0